Cargando…
A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage
BACKGROUND: Germinal matrix hemorrhage is a devastating disease of pre-term infancy commonly resulting in post-hemorrhagic hydrocephalus, periventricular leukomalacia, and subsequent neurocognitive deficits. We demonstrate vascular expression of the adhesion molecule P-selectin after GMH and investi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273747/ https://www.ncbi.nlm.nih.gov/pubmed/37322469 http://dx.doi.org/10.1186/s12974-023-02828-4 |
_version_ | 1785059708925640704 |
---|---|
author | Hatchell, Devin Alshareef, Mohammed Vasas, Tyler Guglietta, Silvia Borucki, Davis Guo, Chunfang Mallah, Khalil Eskandari, Ramin Tomlinson, Stephen |
author_facet | Hatchell, Devin Alshareef, Mohammed Vasas, Tyler Guglietta, Silvia Borucki, Davis Guo, Chunfang Mallah, Khalil Eskandari, Ramin Tomlinson, Stephen |
author_sort | Hatchell, Devin |
collection | PubMed |
description | BACKGROUND: Germinal matrix hemorrhage is a devastating disease of pre-term infancy commonly resulting in post-hemorrhagic hydrocephalus, periventricular leukomalacia, and subsequent neurocognitive deficits. We demonstrate vascular expression of the adhesion molecule P-selectin after GMH and investigate a strategy to specifically target complement inhibition to sites of P-selectin expression to mitigate the pathological sequelae of GMH. METHODS: We prepared two fusion proteins consisting of different anti-P-selectin single chain antibodies (scFv’s) linked to the complement inhibitor Crry. One scFv targeting vehicle (2.12scFv) blocked the binding of P-selectin to its PSGL-1 ligand expressed on leukocytes, whereas the other targeting vehicle (2.3scFv) bound P-selectin without blocking ligand binding. Post-natal C57BL/6 J mice on day 4 (P4) were subjected to collagenase induced-intraventricular hemorrhage and treated with 2.3Psel-Crry, 2.12Psel-Crry, or vehicle. RESULTS: Compared to vehicle treatment, 2.3Psel-Crry treatment after induction of GMH resulted in reduced lesion size and mortality, reduced hydrocephalus development, and improved neurological deficit measurements in adolescence. In contrast, 2.12Psel-Crry treatment resulted in worse outcomes compared to vehicle. Improved outcomes with 2.3Psel-Crry were accompanied by decreased P-selectin expression, and decreased complement activation and microgliosis. Microglia from 2.3Psel-Crry treated mice displayed a ramified morphology, similar to naïve mice, whereas microglia in vehicle treated animals displayed a more ameboid morphology that is associated with a more activated status. Consistent with these morphological characteristics, there was increased microglial internalization of complement deposits in vehicle compared to 2.3Psel-Crry treated animals, reminiscent of aberrant C3-dependent microglial phagocytosis that occurs in other (adult) types of brain injury. In addition, following systemic injection, 2.3Psel-Crry specifically targeted to the post-GMH brain. Likely accounting for the unexpected finding that 2.12Psel-Crry worsens outcome following GMH was the finding that this construct interfered with coagulation in this hemorrhagic condition, and specifically with heterotypic platelet–leukocyte aggregation, which express P-selectin and PSGL-1, respectively. CONCLUSIONS: GMH induces expression of P-selectin, the targeting of which with a complement inhibitor protects against pathogenic sequelae of GMH. A dual functioning construct with both P-selectin and complement blocking activity interferes with coagulation and worsens outcomes following GMH, but has potential for treatment of conditions that incorporate pathological thrombotic events, such as ischemic stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02828-4. |
format | Online Article Text |
id | pubmed-10273747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102737472023-06-17 A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage Hatchell, Devin Alshareef, Mohammed Vasas, Tyler Guglietta, Silvia Borucki, Davis Guo, Chunfang Mallah, Khalil Eskandari, Ramin Tomlinson, Stephen J Neuroinflammation Research BACKGROUND: Germinal matrix hemorrhage is a devastating disease of pre-term infancy commonly resulting in post-hemorrhagic hydrocephalus, periventricular leukomalacia, and subsequent neurocognitive deficits. We demonstrate vascular expression of the adhesion molecule P-selectin after GMH and investigate a strategy to specifically target complement inhibition to sites of P-selectin expression to mitigate the pathological sequelae of GMH. METHODS: We prepared two fusion proteins consisting of different anti-P-selectin single chain antibodies (scFv’s) linked to the complement inhibitor Crry. One scFv targeting vehicle (2.12scFv) blocked the binding of P-selectin to its PSGL-1 ligand expressed on leukocytes, whereas the other targeting vehicle (2.3scFv) bound P-selectin without blocking ligand binding. Post-natal C57BL/6 J mice on day 4 (P4) were subjected to collagenase induced-intraventricular hemorrhage and treated with 2.3Psel-Crry, 2.12Psel-Crry, or vehicle. RESULTS: Compared to vehicle treatment, 2.3Psel-Crry treatment after induction of GMH resulted in reduced lesion size and mortality, reduced hydrocephalus development, and improved neurological deficit measurements in adolescence. In contrast, 2.12Psel-Crry treatment resulted in worse outcomes compared to vehicle. Improved outcomes with 2.3Psel-Crry were accompanied by decreased P-selectin expression, and decreased complement activation and microgliosis. Microglia from 2.3Psel-Crry treated mice displayed a ramified morphology, similar to naïve mice, whereas microglia in vehicle treated animals displayed a more ameboid morphology that is associated with a more activated status. Consistent with these morphological characteristics, there was increased microglial internalization of complement deposits in vehicle compared to 2.3Psel-Crry treated animals, reminiscent of aberrant C3-dependent microglial phagocytosis that occurs in other (adult) types of brain injury. In addition, following systemic injection, 2.3Psel-Crry specifically targeted to the post-GMH brain. Likely accounting for the unexpected finding that 2.12Psel-Crry worsens outcome following GMH was the finding that this construct interfered with coagulation in this hemorrhagic condition, and specifically with heterotypic platelet–leukocyte aggregation, which express P-selectin and PSGL-1, respectively. CONCLUSIONS: GMH induces expression of P-selectin, the targeting of which with a complement inhibitor protects against pathogenic sequelae of GMH. A dual functioning construct with both P-selectin and complement blocking activity interferes with coagulation and worsens outcomes following GMH, but has potential for treatment of conditions that incorporate pathological thrombotic events, such as ischemic stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02828-4. BioMed Central 2023-06-16 /pmc/articles/PMC10273747/ /pubmed/37322469 http://dx.doi.org/10.1186/s12974-023-02828-4 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hatchell, Devin Alshareef, Mohammed Vasas, Tyler Guglietta, Silvia Borucki, Davis Guo, Chunfang Mallah, Khalil Eskandari, Ramin Tomlinson, Stephen A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
title | A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
title_full | A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
title_fullStr | A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
title_full_unstemmed | A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
title_short | A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
title_sort | role for p-selectin and complement in the pathological sequelae of germinal matrix hemorrhage |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273747/ https://www.ncbi.nlm.nih.gov/pubmed/37322469 http://dx.doi.org/10.1186/s12974-023-02828-4 |
work_keys_str_mv | AT hatchelldevin aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT alshareefmohammed aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT vasastyler aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT gugliettasilvia aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT boruckidavis aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT guochunfang aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT mallahkhalil aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT eskandariramin aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT tomlinsonstephen aroleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT hatchelldevin roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT alshareefmohammed roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT vasastyler roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT gugliettasilvia roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT boruckidavis roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT guochunfang roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT mallahkhalil roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT eskandariramin roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage AT tomlinsonstephen roleforpselectinandcomplementinthepathologicalsequelaeofgerminalmatrixhemorrhage |